Microbial adhesion promotes Piezo1 activation to initiate innate immunity
Abstract How mammals mount an effective immune response against infectious agents remains unresolved. Here we identify microbial adhesion to myeloid cells as a critical initiating event that precedes pattern recognition receptor (PRR) engagement. Using a skin infection model with pathogenic bacteria and fungi, we demonstrate that neutrophil recruitment occurs in two sequential phases. The early phase is PRR-independent and instead driven by microbial adhesion, which engages the mechanosensitive ion channel Piezo1 to promote leukotriene (LT)B 4 production. Together with interleukin-1α, LTB 4 induces CXCL1 release, triggering neutrophil infiltration via the same circuit at play during sterile inflammation. By contrast, the late phase is toll-like receptor (TLR)- and CXCL2-dependent, marking a transition to the canonical, pathogen-driven response. Our findings uncover microbial adhesion as a previously unrecognized danger signal that activates innate immunity via mechanotransduction, revealing a paradigm of how immune responses to infection are initiated.
Authors
- S Cozzi
- M R Chelazzi
- F. Granucci
- I Orlandi
- L Marongiu
- M Galli
- A Polissi
- R Ostuni
- G Stucchi
- G Pietrocola
- S Barresi
- G Rocca
- M Vai
- A Lombardo
- A Celant
- A M Martorana
- M Innocenti
- F Colnaghi
Institutions
- Vita-Salute San Raffaele University (IT)
- University of Milan (IT)
- University of Pavia (IT)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- University of Milano-Bicocca (IT)
Publication Details
- Journal
- Nature Immunology
- Published
- 2026-09-09
- DOI
- https://doi.org/10.1038/s41590-026-02643-y
- Primary Topic
- Erythrocyte Function and Pathophysiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Napoli Federico II
- Ministero della Salute
- Associazione Italiana per la Ricerca sul Cancro
- Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II
- National Cancer Institute